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Debate regarding the best surgical option for type
IV thoracoabdominal aortic aneurysms
Michael P. Jenkins, MD,a Stéphan Haulon, MD, PhD,b Roy K. Greenberg, MD,c and
Thomas L. Forbes, MD,d London, United Kingdom; Chru de Lille, France; Cleveland, Ohio; and London,
Ontario, Canada
Conventional open surgical repair, endovascular treatment, and the hybrid technique constitute the three treatment options
for patients with type IV thoracoabdominal aortic aneurysms (TAAAs). Treatment is advocated to prevent rupture but yields
significant risk for spinal cord ischemia, cardiovascular, and renal and respiratory complications, including death. Refinements
in open surgical techniques and branched endovascular graft repair together with the development of hybrid techniques have
been applied to the treatment of type IV-TAAAs to decrease the risk of these complications. However, much of the evidence
of the argument is circumstantial. Large experiences are limited to a few centers worldwide with inherent disparity between
patient groups and several limitations to the construction of a prospective randomized trial. This controversial subject is now
open to discussion, and our debaters have been given the challenge to clarify the evidence to justify their preferred option for
repair of type IV-TAAAs. (J Vasc Surg 2011;54:258-68.)
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lPART I: TREATMENT OF TYPE IV
THORACOABDOMINAL AORTIC ANEURYSMS:
HYBRID TECHNIQUE WITH DEBRANCHING
IS THE BEST OPTION
Michael P. Jenkins, MD, London, United Kingdom
I do not believe there is necessarily a “best option” for
type IV thoracoabdominal aortic aneurysms (TAAAs), per
se. What would be optimal treatment for 1 patient may not
be the best option for another. If the best option is based on
the treatment modality applied to the largest majority, then
the answer would depend on the institution and the patient
population served. However, I believe the best option is
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258ruly patient-specific and, therefore, the best treatment is
eally given by the institution, which can offer all three
reatment options and select the patients most suitable for
hat intervention.
TAAAs tend to present in an elderly population, often
ith extensive comorbidity. They are either identified inci-
entally or present late with pressure symptoms as a conse-
uence of size. Untreated, despite the presence of comor-
idity, the mortality from aneurysm rupture is high.1 It is in
hese very elderly patients with extensive comorbidity but
arge aneurysms, where there is no perfect treatment strat-
gy that the least invasive, cost-effective, and readily applied
echnique is therefore desirable.
Outside the excellent results from individual single
enter publications,2 population studies show that the tra-
itional approach to TAAA treatment shows room for
mprovement with a 30-day elective mortality of 19% (40%
or those over 80 years) in the state of California.3 Whether
less invasive technique or centralization of patients to
igher volume centers (or both) is the answer is uncertain,
ut my remit is to look at the various merits of the current
echniques available.
The visceral hybrid technique of extra-anatomic deb-
anching combined with aneurysm exclusion with conven-
ional covered aortic stent grafts was designed to eliminate
ome of the known adverse aspects of conventional open
horacoabdominal surgery to treat the most extensive an-
urysms.4,5 The absence of a thoracotomy was seen as an
dvantage in patients with respiratory compromise, and the
ack of aortic cross-clamping and consequent reperfusion
njury allowed patients with reduced cardiac reserve to
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Volume 54, Number 1 Jenkins et al 259remain hemodynamically stable. The combination of ab-
dominal surgery and relatively little cardiac stress has al-
lowed the technique to be applied to unfit patients. It is
questionable whether this can be justified, but human
nature dictates that some patients with very large aneu-
rysms will want to consider any option available. This
makes comparison with other series in the literature
difficult for a number of reasons. First, in general, most
open surgical series report a younger, fitter group of
patients, and most fenestrated/branched series, by defi-
nition, report outcomes in patients anatomically suitable
for endovascular treatment. Second, the literature is
somewhat contaminated by many small series very early
in the learning curve of the procedure, and most series
contain a variety of indications and extent of aneurysmal
involvement.6 Many authors are reporting the technique
rather than a defined group of patients to which it has
been applied. Furthermore, the visceral hybrid technique
has been taken up widely and is now adopted by centers
with little previous experience of treating patients with
TAAAs. Although it is clearly desirable that as many
patients as possible are at least considered for treatment,
I would question the wisdom of a center without exten-
sive open surgical or fenestrated/branched experience
embarking on a treatment program as patients will not be
given all the options available.
The visceral hybrid procedure has been used to treat
many types of aneurysms and I do not doubt that it can
be used to treat type IV-TAAAs (the first reported case
was in a patient with a type IV extent aneurysm),4 but the
question here is whether it should. Without giving too
much away at the outset, I believe that, except under
certain unusual circumstances, the answer is unequivo-
cally “no.”
Evidence. Not all series classify the extent of aneurys-
mal involvement and it is therefore difficult to make good
outcome comparisons. What is clear, however, is that
type IV-TAAAs make up a very small percentage of all
aneurysms treated by this technique (Table). Looking
through the published series that documented TAAA
extent,6-14 only 12% of cases involved treatment of type
IV extent aneurysms. Within this group of 270 cases,
Table. Absolute numbers of type IV aortic aneurysms
reported in visceral hybrid series
Publication
No. of type
IV cases
Total no.
of cases
Quiñones-Baldrich et al10 4 20
Lee et al7 7 17
Siegenthaler et al8 2 21
Drinkwater et al9 1 107
Donas et al6 13 58
Gawenda et al11 2 6
Biasi et al12 0 18
Fulton et al14 2 10
Chiesa et al13 2 13107 were from one publication,9 which described a hingle type IV extent case and that was a patient whom
ad already undergone open type IV open surgery and
epresented with a blowout of the proximal anastomosis.
believe this tells us that there are probably better ways
f repairing such aneurysms.
The majority of type IV-TAAAs can be repaired via a
ubcostal incision15 and, therefore, there is no advantage of
horacotomy avoidance. Admittedly, there is potential for
emodynamic instability and cardiac complications of
ross-clamping at the level of the diaphragm, but with
areful optimization of ischemic heart disease, such prob-
ems can be reduced if not entirely eliminated. The litera-
ure would seem to confirm this with contemporary series
50 consecutive cases reporting very good elective 30-day
ortality rates for open type IV surgery – 3% Houston,16
% Edinburgh,17 and 3.5% St Mary’s.18 There is ample
vidence to show that open repair is durable in survivors
ith very low rates of aneurysm-related complications in
he long term.19 If we accept that such mortality figures are
ifficult to improve upon, we have to search for an area
here a different approach may confer some advantages in
erms of morbidity or recovery rate. Unfortunately, I do
ot believe the visceral hybrid is of benefit here either – a
ajor laparotomy with extensive dissection is necessary and
f anything, a greater length of aortic coverage is necessary
o obtain a seal at the stent landing zones, theoretically
ncreasing the risk of spinal cord ischemia. This risk, how-
ver, is low for type IV extent aneurysms and with a
enestrated/branched solution is offset by the substantially
ess invasive approach afforded by this technique, as long as
he internal iliac circulation is preserved. However, paraple-
ia is not eliminated by a totally endovascular approach 
n Roselli’s series of 73 cases (62% type IV), the paralysis
ate was nearly 3%.20
Indications for visceral hybrid in type IV thoraco-
bdominal aortic aneurysms. So we must now ask our-
elves if the complexity and unproven durability of the
isceral hybrid approach is ever justified for type IV extent
AAAs. I would agree that if a patient is relatively young
nd fit, conventional open surgery is a proven strategy. If
he anatomy is suitable and the funds available, a fenestrat-
d/branched approach is an option if the elective nature of
resentation allows time for a bespoke device to be manu-
actured.
To play devil’s advocate, one could argue that if applied
o too many cases, the visceral hybrid procedure, if used
ndiscriminately, could be said to be hampered by both the
arly disadvantages of open surgery and the late ones of
he endovascular approach. However, as always, case
election is the key and choosing the right procedure for
n individual patient is paramount. For relatively unfit
atients with types I to III aortic aneurysms and anatomy
nsuitable, or presentation too acute for a totally endo-
ascular approach, one can justify a visceral hybrid ap-
roach. I am not convinced that this can be extrapolated
o type IV aneurysms for reasons outlined above, but
here are certain circumstances where this approach may
ave advantages:
R1
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blowout);
● extra-anatomical bypass to allow extension of a previ-
ous infra/juxta-renal endovascular repair for proximal
neck dilatation;
● significant visceral and renal artery stenosis combined
with a type IV-TAAA;
● patients with anatomy precluding a subcostal approach
with concomitant respiratory compromise;
● gross circumferential calcification at the potential aor-
tic clamp site;
● as a temporary bridging procedure for symptomatic
mycotic aneurysms affecting the visceral segment.
CONCLUSIONS
Publications from certain major US institutions would
suggest that the gold standard method of treatment for all
TAAAs is open surgery. I would agree that this is a partic-
ularly good option for type IV aneurysms in fit patients.
There is consistent evidence in the literature showing ex-
cellent results from higher volume institutions, both within
the United States and Europe. However, such a conclusion
can only be applied to those patients afforded the opportu-
nity of treatment in such institutions, and population stud-
ies prove that the majority of patients fair much less well.
The reduction in invasiveness with a fenestrated/
branched approach is beyond question, but anatomic con-
straints, manufacturing delays, and financial considerations
continue to limit applicability. Despite the above, for suit-
able patients, and when funding allows, a totally endovas-
cular approach remains a desirable option. Which leaves the
visceral hybrid operation as very much the third choice for
type IV-TAAAs. The advantages of this approach can really
only be gained when applied to more extensive aneurysms,
and I do not think there is any justification for its routine
use in uncomplicated type IV-TAAAs. There are special
circumstances (as outlined above) where I believe it is a
good option, and for such cases it remains a very flexible
and seemingly durable treatment.
To finally consider the debate again – there can be no
“best option” for all patients. I do not feel that “best
option” can be substituted for “only option” in units
without open thoracoabdominal surgical or fenestrated
endovascular experience. Although the visceral hybrid
technique has undoubtedly allowed patients to be treated
in local hospitals rather than be referred to larger special-
ized units, it is questionable whether the results justify this
strategy. The key to successful outcomes in such patients is
applying the best treatment to the most suitable patient,
and, as such, a unit should be able to offer all three options.
Certainly, there are cases where all three treatment strate-
gies could be used, but when weighed up carefully, in the
majority of cases, one will be seen as superior. The debate,
therefore, hinges on which treatment is best for an individ-
ual patient rather than which is the best treatment, per se.EFERENCES
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THORACOABDOMINAL AORTIC ANEURYSMS:
FENESTRATED STENT GRAFT REPAIR IS NOW
THE BEST OPTION
Stéphan Haulon, MD, PhD, and Roy K. Greenberg,
MD, Lille France; and Cleveland, Ohio
The treatment of aneurysmal disease of the aorta has
seen profound changes in the past 2 decades since Parodi et
al1 performed the first endovascular aneurysm repair. In
this period, devices have evolved from simple covered tu-
bular stents to highly complex, custom-designed devices
incorporating branches and fenestrations which allow treat-
ment of complex aneurysms of the abdominal and thoracic
aorta. The utility of fenestrated devices for the treatment of
juxta-renal aneurysms is now well established with several
large series confirming satisfactory intermediate-term out-
comes.2-4 When aneurysms involve the renal and visceral
vessels, the risks of open surgery increase, and, therefore,
the potential benefit of an endovascular option increases as
well. The treatment of such aneurysms with fenestrated
devices began in 2002, and has become increasingly more
popular as the implantation technique and device design
has evolved. Publications addressing the outcome of endo-
vascular repair of thoracoabdominal aortic aneurysms
(TAAAs) have been quite favorable compared with the
results published for open surgery.5-10 The endovascular
procedure has been relegated to larger volume centers of
excellence, much like most open TAAA repairs. However,
much of the published literature on endovascular treatment
of TAAAs has reported outcomes for the conglomerate
group of all types of TAAAs, without specifically focusing
upon any given subtype of TAAA. This has resulted in
considerable heterogeneity with respect to reported out-
comes and conclusions. This report focuses on the out-
comes and assessment of the results when the analysis is
limited to type IV-TAAA.11-13
METHODS
Retrospective reviews of two prospective databases,
including all patients undergoing endovascular repair of
abdominal aortic, thoracoabdominal, and thoracic aneu-
rysms at the Centre Hospitalier Regional Universitaire de
Lille, Lille, France, and the Cleveland Clinic, Ohio, United
States. From this database, we selected the patients who
had repair of type IV-TAAAs using fenestrated or branched
endovascular devices. All patients treated were considered
high-risk for open repair of their aneurysm as described in a
previous publication.5 In an effort to define the extent of
the design and plan the intended repair, anatomic images
were reconstructed on a 3D imaging workstation (Aquarius
WS, Calif) and centerline of flow reconstructions were used
to design a customized endoprosthesis. The design process
and implantation technique have been described in detail
previously and are beyond the scope of this article.10,14 For
the purposes of this article, we defined a type IV-TAAA as
being any aneurysm that required a branch (side-arm or
reinforced fenestration) for the superior mesenteric artery sSMA) and at least one of the renal arteries, with a proximal
ealing zone above the visceral segment (Fig), akin to type
V-TAAA as defined by the Crawford classification.15 Fol-
ow-up clinical assessment, laboratory testing (including
stimated glomerular filtration rate evaluation), computed
omographic angiography (CTA), duplex ultrasonography,
nd plain chest and abdominal radiographs were performed
efore discharge or within 1 month of follow-up, then
nnually thereafter. Additional follow-up studies were ob-
ained at 6 and 18 months in selected patients.
Statistics. Means are expressed with the SD. Kaplan-
eier life-table analysis techniques were used to estimate
urvival during follow-up.
ESULTS
Between January 2004 and March 2010, 231 patients
ith type IV-TAAAs were treated with an endoprosthesis.
atient characteristics are shown in Table I. All devices were
uccessfully deployed as planned. There were no acute or
ate conversions to open surgical repair.
Mortality, rupture, and spinal cord ischemia. There
ere no intraoperative deaths. Thirty-day mortality was
.6%. Twenty-four-month survival was estimated at 83%.
here were no aneurysm ruptures after endovascular repair.
pinal cord ischemia developed in 2 patients (1%).
Branch patency. Target vessel patency was 97.8% at a
ean follow-up of 15 months.16 In this analysis, there were
ine renal branch occlusions (1.9%) that occurred at a mean
f 3 months after implantation. There were no new occlu-
able I. Patient characteristics
atient characteristics n  231
ge, mean  SD 67.9  9
ale gender, % 68
moking, % 58
iabetes mellitus, % 12
ardiac
History of CAD, % 47
EF, mean  SD 54.2  11.2
EF 0.30, % 5
ulmonary
History of COPD, % 31
FEV1, mean  SD 1.9  0.7
FEV1 1 L, % 17
FEF 25% to 75%, mean  SD 1.1  0.8
FEF 25% to 75% 30% of expected, % 42
istory of cancer, % 15
MI, mean  SD 26.8  5.1
enal
GFR, mean  SD 69.6  28
40% 15
60% 34
ortic diameter, mm, mean  SD 61  1.6
istory of surgery for proximal aorta, % 14
istory of surgery for distal aorta, % 28
AD, Coronary artery disease; EF, ejection fraction; COPD, chronic ob-
tructive pulmonary disease; FEV1, forced expiratory volume in 1 second;
EF, forced expiratory flow; BMI, body mass index; GFR, glomerular
ltration rate.ions noted after the 1-year CT scan. Hemodialysis was
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were three SMA occlusions (1.3%), one of which had a fatal
result. The other 2 patients presented with symptoms akin
to chronic mesenteric ischemia and were successfully
opened with endovascular techniques. An asymptomatic
celiac trunk occlusion was depicted in 3 patients. These
results are summarized in Table II.
Aneurysm growth (5 mm) was depicted in 3 patients
during follow-up. A secondary endoleak was depicted and
treated in these 3 patients (two type 2 and one type 3
endoleaks).
Freedom from secondary intervention was estimated at
93% and 73% at 30 days and 24 months, respectively. A
total of 44 secondary procedures were performed during
follow-up, including 12 renal artery stenting and eight type
2 endoleak embolizations. Freedom from endoleak was
estimated at 84% and 75% at 30 days and 24 months,
respectively.
DISCUSSION
Open surgery for thoracoabdominal aortic
aneurysms. Traditionally high morbidity and mortality
figures associated with open repair of thoracoabdominal
aneurysms and the rapid progress in endovascular technol-
ogies have driven the evolution of endovascular techniques
to treat this particular pathology. Improvements in adjunc-
tive measures at open surgery have included the introduc-
tion of distal aortic perfusion and cerebrospinal fluid drain-
age, along with moderate passive hypothermia, active
visceral cooling with blood or crystalloid solution, and
aggressive intercostal artery reattachment. The introduc-
tion of these measures has helped one reference center
reduce their incidence of immediate neurological deficit
from 6.8% to 2.4%.17 However, these figures pertain to the
treatment of all types of TAAAs without providing details
of the rates of neurologic deficit for each of the subtypes of
TAAAs and also describe only immediate neurologic defi-
cits. When such results are considered, the reported overall
30-day mortality rate of 14% seems to be quite high.
Another large series of 2286 open TAAA repairs18 reported
an overall 30-day mortality rate of 5%, a paraplegia/para-
paresis rate of 3.8%, and a renal failure rate of 5.6%. How-
ever, when results are limited to type IV-TAAAs, the risks
decrease to 3%, 1.4%, and 5.4%, respectively, in the group
of 427 type IV-TAAAs. Additional complications included
pulmonary issues which occurred in 734 patients (32.1%),
cardiac events in 181 patients (7.9%), renal failure requiring
hemodialysis in 129 patients (5.6%), and stroke in 40
patients (1.7%) in this series. A more recent series from the
Table II. Main outcomes
30-Day mortality 2.6%
2-Year mortality 18%
Spinal cord ischemia 1%
Permanent dialysis 1%
Target vessel patency 97.8% at 15 monthsUnited Kingdom details experience of 53 open repairs of aype IV-TAAAs (n  44) or suprarenal (n  9) aneurysms
t a TAAA reference center for all of Scotland.19 In this
eries, which is probably the most comparable to our own,
he overall 30-day mortality was 6%, cardiac complications
ccurred in 19%, respiratory complications in 38%, and
araplegia in 2%, in addition to 6% of patients requiring
emodialysis postoperatively.
Reports from centers of excellence are critical for eval-
ating the technology in question; however, the ability to
isseminate the technique in a safe and efficacious manner
s the subject of larger databases and necessary to get a more
ccurate picture of the “real world” experience. With re-
pect to TAAA repair, a review of the Nationwide Inpatient
ample database (a discharge database representing 20% of
S hospitals) showed that perioperative mortality after
lective TAAA repair was 22.3%, with a greater mortality
isk in hospitals with lower procedure volumes.20 A more
ecent California statewide study of more than 1000 TAAA
epairs published a 19% rate of overall perioperative mor-
ality21 and noted a 1-year mortality rate of 31%.
Hybrid repair of thoracoabdominal aortic
neurysms. Reports from various centers describing the
ybrid approach to treatment for TAAAs have produced
isparate results. This technique, which involves visceral
ortic debranching followed by staged or immediate endo-
ascular aortic relining, is generally credited to the St
ary’s Hospital group from London who published a
eries of 29 patients in 2006.22 This initial report achieved
30-day mortality rate of 13% with no associated paraple-
ia. This series, along with a number of other small volume
tudies, were reviewed by Donas et al23 in 2007 who found
n overall operative mortality rate of 10.7% and a paraplegia
ate of 0% in 58 patients from 13 published reports. Unfor-
unately, the initial enthusiasm for this approach has been
omewhat tempered by more recent reports. Chiesa et al24
ublished a series of 31 hybrid procedures at his unit in
ilan and reported perioperative mortality and parapare-
is/paraplegia rates of 19.4% and 9.6%, respectively. Within
his paper, a review of published series of greater than 10
atients yielded six studies describing 107 patients. The
alculated perioperative mortality rate was 15.6% with para-
aresis/paraplegia in 7.2%. Renal failure was noted in 9.9%
n this review. Interestingly, the largest published series to
ate is a multicenter series of 107 patients involving the
riginal St Mary’s group and units at Heidelburg and
unich in Germany.25 The operative mortality there was
4.95% and, interestingly, the incidence of spinal cord
schemia was 12.1% with permanent paraplegia in 8.4%,
hich is in contrast to the 0% reported in the original St
ary’s publication.22
Unfortunately, very little data specific to this approach
or type IV-TAAAs is published, with most of the afore-
entioned series describing experiences predominantly
ith types I, II, and III TAAA. The general attitude seems
o limit hybrid repairs to more extensive aneurysmal dis-
ase, whereas when the disease remains inferior to the
iaphragm either a pure open surgical or pure endovascular
pproach is most commonly performed.
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aneurysms. At least five series of wholly endovascular re-
pair of TAAAs consisting of more than 10 patients have
been published to date, providing data on 410 patients
altogether.5-8,10 The 30-day mortality has ranged from
5.5% to 12% and spinal cord ischemia rates from 2.7% to
16.7%. Dialysis rates have been between 1.4% and 9.1%
with the lower rates being reported in the larger series. In
the largest of these series from Cleveland,5 the endovascu-
lar experience was presented in tandem with the open
surgery experience over the same 67-month period. Pa-
tients undergoing endovascular repair were statistically
older and had more comorbidities. Outcomes between the
open repair group and the endovascular repair group were
broadly similar with no significant difference in 30-day or
1-year mortality data, implying that results equivalent to, or
even superior than, open surgery in healthy patients can be
obtained in an older, sicker patient population with an
endovascular approach. The authors in this series also com-
pared the 30-day mortality and spinal cord ischemia rates
between open (n 64) and endovascular surgery (n 69)
Fig. Graft plan A, of an endograft with four fenestratio
aneurysm situated above a previous aortic tube graft repa
the postoperative computed tomography (CT) scan showing tpecifically for type IV-TAAA repairs and found no signif-
cant difference between the groups. Interestingly, how-
ver, 1-year mortality in the open group at 22% was almost
wice that of the endovascular group at 12% even when the
ndovascular patients were a considerable less robust
roup.
The data presented in the Results section are the largest
eries published to date specifically concerning the endo-
ascular treatment of type IV-TAAAs. The patients in this
eries were considered high risk for open surgical repair and
ntuitively one would expect that their outcomes would be
orse than those attained at open repair in fitter patients.
his, however, has not been the observed experience, and
he outcomes achieved in this group of patients seem
xcellent when compared to those achieved at open sur-
ery. Critics of the endovascular approach to these aneu-
ysms raise concerns about the long-term integrity of the
ndoprosthesis and the visceral branches but experience to
ate with branched and fenestrated endografts for the
reatment of juxtarenal aneurysms has shown the devices to
e durable in the medium and long term.2-4 Indeed, one of
ed to treat a patient with a type IV thoracoabdominal
terior B, and lateral C, 3-D volume rendering images ofns us
ir. Anhe endograft in good position with all branches patent.
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ing fenestrated endovascular repair of juxtarenal aneu-
rysms, has demonstrated a branch patency rate of 93.3%
with up to 5-year follow-up suggesting good durability of
the devices.4 All branch occlusions in this series occurred in
the first 2 years of follow-up. No aneurysm-related death
occurred at 5-year follow-up. A further study from the
Cleveland Clinic16 with a mean follow-up of 26 months
(range, 9 months-6 years), followed the fate of 518 renal
arteries stented during the course of endovascular repair of
juxtarenal or thoracoabdominal aneurysms with either cov-
ered or uncovered stents. A total of 18 arteries (3.5%)
occluded during follow-up with a rate of only 2.2% ob-
served in cases where covered stents were deployed and a
rate of 4.5% in cases where uncovered stents were used.
Most renal stent occlusions (11 of the 18) occurred before
the 1-month CT scan. The remaining seven occlusions
occurred between the 1-month and 6-month studies.
There were no late renal stent occlusions. Thirty-six renal
stent stenoses were detected during follow-up, but only
seven required secondary procedures. Again, the covered
stents performed better with a 2.5% rate of stenosis, vs a
10% rate of stenosis as observed with uncovered stents.
As mentioned in the introduction, endovascular ap-
proaches to repair of juxtarenal aneurysms and type IV-
TAAAs are technically comparable apart from the minor
difference in the degree of aortic coverage required and also
the routine necessity for a branch or fenestration for the
SMA and/or the celiac trunk. If the extra degree of aortic
coverage involved were to be a genuine problem, then one
would expect to see a significant incidence of spinal cord
ischemia in patients undergoing endovascular repair, but
this does not seem to be the case with a small rate of spinal
cord ischemia noted in our series (1%). In addition, excel-
lent target vessel patency rates, uniformly in excess of 90%,
have been reported in all the series describing endovascular
repair of TAAAs to date and the aforementioned Dutch and
Cleveland Clinic studies4,16 suggest that if problems with
stent patency are to occur, then they will occur early rather
than late. Indeed, it is likely that the presence of additional
or improved stents for the visceral vessels may in fact offer
protection against device migration.
In spite of the high quality long-term multicenter en-
dovascular data, the endovascular data seems to be more
robust than any of the surgical reports. There has never
been a multicenter study on the open surgical treatment of
thoracoabdominal aneurysms. There is no consensus on
how and when open surgical patients should be reimaged,
in spite of a considerable risk of failure after open surgery.26
In this light, it seems a little short-sighted to criticize the
lack of long-term data or hypothesize about failing device
integrity, when no well-studied alternative exists. In fact,
the data in this series support the application of these
technologies to treat type IV-TAAAs over an open surgical
approach, when used by skilled clinicians operating in
centers of excellence.
The debate regarding the best option for repair of
TAAAs will no doubt continue, but when looking at this
1opic, it is important to differentiate between the different
ypes of TAAAs to inform policy. Our series demonstrates
he safety of the fenestrated endograft approach to type
V-TAAA repair. Outcomes from various studies have
hown at least equivalence of the endovascular approach in
erms of spinal cord ischemia and 30-day mortality. One-
ear survival may even be improved. The incidence of
ardiac, respiratory, and renal complications seems to be
ignificantly greater in patients undergoing open surgery
nd, given the excellent results of fenestrated endografting
or other analogous pathologies it is now, we believe, the
referred option for repair of type IV-TAAAs.
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PART III: OPEN REPAIR IS THE BEST OPTION
FOR TYPE IV THORACOABDOMINAL AORTIC
ANEURYSMS
Thomas L. Forbes, MD, London, Ontario, Canada
Thoracoabdominal aortic aneurysms (TAAAs) have
long proven to be one of the most challenging clinical
scenarios to confront vascular surgeons. Open repair has
traditionally required extensive aortic dissection, often in-
volving the thoracic and abdominal cavities, and has re-
sulted in not insignificant rates of mortality and major
morbidity, including cerebral and cardiovascular events,
spinal cord ischemia, and renal dysfunction. Pharmaco-
logic, anesthetic, and surgical adjuncts have been devel-
oped in response to these adverse outcomes and have at
least partially mitigated their occurrence, but not com-
pletely.1
More recently, refinements in surgical technique have
been developed in the efforts to improve these outcomes.
With evolving endovascular technology, two major shifts in
surgical approach have led to a hybrid approach, combining
visceral and renal artery debranching with standard thoracic
stent grafts,2 and a totally endovascular approach, which up
until recently has involved a customized branched or fenes-
trated endograft.3 Both of these innovations in surgical spproach have their place, and some distinct advantages,
nd will be discussed by my fellow contributors.
At first glance, the more surgical options there are, the
ore confusing the choice of that which is most appropri-
te seems to be. However, an important point requires
epeating before entering this discussion, namely the ana-
omic extent of the TAAA. The current discussion is cen-
ered on the surgical treatment most appropriate for Craw-
ord type IV-TAAAs. By definition, these aneurysms are
imited to the abdominal cavity and the aorta below the
iaphragm.4 With the debate confined to this lesion, it is
lear that open repair is the preferable option, with only a
mall number of exceptions.
Results of open repair. Open repair of type IV-TA-
As has a long history of good outcomes. Because of its
imited extent, relative to type I to III, open repair is
nvariably a one-cavity operation (abdominal) with suprace-
iac proximal aortic control, graft interposition, and renal
nd mesenteric revascularization in a manner dictated by
he aneurysm morphology and surgeon preference. Al-
hough specific adjuncts that minimize adverse sequelas
ave been more widely utilized in types I to III TAAAs,
hey have been used less often with type IVs. Postoperative
enal dysfunction has long been observed to be an indepen-
ent predictor of mortality following open TAAA repair,1
nd up to 15% of patients with TAAAs will exhibit some
lement of preoperative renal dysfunction.4 For these rea-
ons, the most commonly used adjunct with open repair of
ype IVs has invariably been renal perfusion. In a recent
eport that comprised a total of 509 TAAAs, the Houston
roup described their choice of adjuncts and outcomes in
25 type IV-TAAAs.5 Whereas left heart bypass was used in
he majority of type I and II thoracoabdominal aneurysms,
t was not used in any type IV aneurysms. Renal perfusion
as used in the majority of type IVs (98.4%) while celiac or
uperior mesenteric artery perfusion was not used in any,5
n contrast to the preference of some groups.4 Cerebrospi-
al fluid drainage, in an attempt to prevent spinal cord
schemic complications, was used in a quarter (25.6%) of
atients with type IV.5 With this approach of open repair of
ype IV-TAAAs with selected adjuncts, optimal outcomes
re possible. The recent report from Houston included a
.4% rate of dialysis-dependent renal failure at the time of
ischarge, a 1.6% rate of permanent paraplegia, and a
erioperative mortality rate of 8.0%.5 In a multivariate
nalysis, type IV-TAAAs were independently associated
ith a lower risk of an adverse outcome.
However, these results were achieved at a center of
xcellence with a long history of experience with thoraco-
bdominal aneurysms. Are these results with open repair
chievable at other centers, with less experience? This is a
uestion certain to be raised by the other discussants. In a
idely quoted paper, statewide outcomes from California
ere analyzed, and the University of California – Los
ngeles group reported a 19% 30-day and 31% 1-year
lective mortality rate in over 1000 thoracoabdominal an-
urysms over a 10-year period (1991 to 2002).6 These
obering results were achieved at a variety of hospitals of
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umes. The authors are the first to admit, however, that this
study had several important limitations. First of all, mortal-
ity was the only outcome measure reported in this database.
Information regarding other important outcomes, includ-
ing paraplegia and renal dysfunction, is distinctively lacking
in this statewide database. Most importantly, in the context
of the current discussion, is the lack of anatomic extent
information contained in this database. All aneurysms were
grouped together and the results reported are reflective of a
pool of aneurysms of all anatomic extents, types I to IV.
There is no reason to suggest that this statewide series is any
different from other reported experiences where approxi-
mately 25% of thoracoabdominal aneurysms were type IV
aneurysms.5 Therefore, it is likely that these California
results predominantly represent an experience with more
extensive TAAAs with a more minor contribution of type
IVs (approximately 25%).
Open repair VS hybrid repair. Hybrid repair of
TAAA, combining visceral and renal debranching and en-
dovascular repair, was first reported in 1999.7 Since then,
several centers have advocated its use as a less invasive
alternative to open repair of TAAAs. Classically, it obviates
the need for aortic clamping via debranching of the visceral
aorta with retrograde bypasses to the mesenteric and renal
arteries, which are subjected to sequential ischemia and
reperfusion. This is followed by placement of a standard
thoracic endograft across the aneurysmal visceral aorta at
the same sitting, or more commonly in a staged manner.
Several groups have attempted to compare their expe-
riences with hybrid repair and open repair of TAAAs.2,8
The Cleveland Clinic group reported their outcomes after
staged hybrid repair of 13 TAAAs which were deemed too
high risk for open repair.8 Although they concluded that
this approach is feasible, it is not without its adverse out-
comes. Specifically, 2 of the 13 patients suffered from
paraplegia, 2 patients required short-term hemodialysis, 3
of the 13 patients died within 30 days, and there were two
instances of late aneurysm-related deaths. It is important to
note that only 1 of these 13 patients was a type IV-TAAA.
In a larger analysis, the group from Massachusetts
General Hospital compared their experience with 23 hybrid
repairs with 77 open repairs of thoracoabdominal aneu-
rysms in high-risk individuals.2 Although the hybrid repairs
were performed in higher risk patients, they reported sim-
ilar 1-year survival rates for open (73%) and hybrid (68%)
cohorts. Reinterventions after hybrid repair were not infre-
quent with 22% of hybrid patients developing an endoleak
with three instances requiring an endovascular reinterven-
tion. However, although any comparison of these ap-
proaches is welcomed, the relevance of this experience to
the current discussion is severely limited by the under-
representation of type IV aneurysms in the hybrid cohort.
There were no type IV aneurysms treated via a staged
hybrid approach in this series.
In the absence of a good comparison of hybrid and
open repair of type IV aneurysms, we will rely on surgical
common sense. Both methods of repair require a large Cbdominal exposure, so although the hybrid approach in-
olves an endovascular component, it is hardly less invasive.
he hybrid approach actually involves a more extensive
ortic repair, often extending into the descending thoracic
orta with a stent graft, whereas open repair is limited to the
ubdiaphragmatic aorta. This extension into the thoracic
orta, and the resulting occlusion of distal thoracic inter-
ostals arteries, may actually increase the risk of spinal cord
schemia with hybrid repair compared to open repair. Ad-
itionally, with up to 22%2 of hybrid patients developing an
ndoleak, this repair may have to be extended even more
roximally, increasing the risk of paraplegia even further.
nother disadvantage of the hybrid approach as it is cur-
ently practiced is the delay in therapy inherent in a staged
pproach. Although probably under-reported in the litera-
ure, most investigators have had a patient rupture their
neurysm between stages of this procedure.
It is debatable whether a hybrid approach, with sequen-
ial visceral and renal ischemia during debranching, is less
hysiologically stressful then supraceliac clamping and ad-
unctive perfusion measures. Both involve a measure of
enal and mesenteric ischemia, and, as shown in the Mas-
achusetts General Hospital series,2 patients at prohibitive
isk of open repair for type IV aneurysms do not clearly
enefit from a hybrid approach and should be seriously
onsidered for a nonoperative approach.
In this comparison of open and hybrid approaches for
ype IV-TAAAs, there remains little question that open
epair is the preferable operation for patients who are
hysiologically appropriate for an operative intervention.
t our center, this is certainly the preferred option in the
ast majority of cases, with a hybrid repair reserved for
atients with very specific anatomic patterns, usually in-
luding reoperative aortic surgery and more urgent indica-
ions.
Open repair vs endovascular repair. Admittedly, to-
ally endovascular repair of type IV thoracoabdominal an-
urysms is an inherently attractive option. Since its initial
eport in 2005,9 further experience has been gained with
his approach, primarily at selected individual centers. Al-
hough work has progressed in the development of a stan-
ardized design, the majority of reported experience in-
olves customized branched and/or fenestrated devices
rom a single manufacturer (Cook Medical, Bloomington,
nd). The fenestrations and branches are then mated with
heir corresponding visceral or renal arteries with a combi-
ation of balloon expandable or self-expanding covered
tents, obviating the requirement for visceral ischemia. This
s attractive, especially in higher risk individuals who might
ot tolerate thoracic aortic clamping and visceral or renal
schemia. Inherent in this approach, however, are several
isadvantages, including the development of the necessary
nterventional skills that are required, the time period and
ost required for graft planning and manufacturing, and the
imitation of this technology to a subset of anatomically
ppropriate patients.
In an important comparative study, the group from the
leveland Clinic compared their results after open and
a
p
t
u
C
c
c
o
b
r
t
a
a
l
r
R
1
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 1 Forbes and Ricco 267totally endovascular repair of TAAAs.3 In this large study,
over 700 patients were treated with endovascular patients
being older, having more extensive comorbidities, and
more likely to have had previous aortic repairs. Despite this,
mortality at 30 days (5.7% endovascular and 8.3% open)
and 1 year (15.6% endovascular and 15.9% open) was
comparable. A statistically insignificant trend toward more
frequent spinal cord complications was observed in the
open repair group with extent of repair being an indepen-
dent predictor of spinal cord complications after multivar-
iate analysis.
Reports such as these, from centers such as the Cleve-
land Clinic, are certainly promising, but it continues to be
premature to recommend a totally endovascular approach
as the preferred method of repair for all type IV thoracoab-
dominal aneurysms. Generalizability of these results be-
yond a relatively small number of international centers
remains a concern, and is hindered by cost, interventional
skill development, and regulatory issues in certain parts of
the world. This question of generalizability of an endovas-
cular approach is at least as relevant as those similar con-
cerns regarding open repair. Although advances have been
made in the development of a standardized stent graft10
this approach continues to require customized stent grafts
too frequently to permit wider spread adoption and utili-
zation in a timely fashion.
Several anatomic issues require further elucidation before
wider adoption of a totally endovascular approach. Specific
hurdles include tortuous thoracic aortas which can inhibit
accurate endograft delivery and deployment, and small visceral
and renal arteries which can limit long-term patency of cov-
ered stents. Additionally, although the vast majority of type IV
thoracoabdominal aneurysms are degenerative in nature, a
certain proportion are of other etiologies that offer unique
challenges and limitations for an endovascular approach. In
the report from Houston, 8.8% of patients with type IV-
TAAAs had a documented connective tissue disorder or Mar-
fan syndrome while 8% had a chronic dissection.5 These
etiologies can be challenging, regardless of method of repair,
but have unique implications for endovascular repair, includ-
ing uncertain longer-term outcomes.
Much work has been done in the development of an
endovascular approach, but much more is needed before
recommending this repair as the preferred option for type
IV thoracoabdominal aneurysms. In our practice, open
repair remains the preferred option for type IV-TAAAs,
with a totally endovascular approach reserved with those
aneurysms (type IV-TAAs) due to several limitations, including poor-risk
p
n
r
inatomically appropriate, and physiologically higher-risk
atients with moderate sized aneurysms who can tolerate
he time required for customized graft planning and man-
facturing.
ONCLUSION
When restricting the discussion to type IV-TAAAs, the
hoices are clear. In the vast majority of patients, deemed
andidates for repair, open repair remains the preferred
ption. Hybrid repairs have limited applicability and should
e reserved for specific anatomic patterns, usually involving
edo aortic surgery and more urgent presentations. Al-
hough promising, wider adoption of a totally endovascular
pproach for type IV-TAAAs is not currently appropriate
nd this technology should be reserved for those physio-
ogically higher-risk patients at centers with sufficient expe-
ience.
EFERENCES
1. Safi HJ, Estrera AL, Azizzadeh A, Coogan S, Miller CC. Progress and
future challenges in thoracoabdominal aortic aneurysm management.
World J Surg 2008;32:355-60.
2. Patel R, Conrad MF, Paruchuri V, Kwolek CJ, Chung TK, Cambria RP,
et al. Thoracoabdominal aneurysm repair: hybrid versus open repair. J
Vasc Surg 2009;50:15-22.
3. Greenberg RK, Lu Q, Roselli EE, Svensson LG, Moon MC, Hernandez
AV, et al. Contemporary analysis of descending thoracic and thoraco-
abdominal aneurysm repair: a comparison of endovascular and open
techniques. Circulation 2008;118:808-17.
4. Conrad MF, Cambria RP. Contemporary management of descending
thoracic and thoracoabdominal aortic aneurysms: endovascular versus
open. Circulation 2008;117:841-52.
5. Wong DR, Parenti JL, Green SY, Chowdhary V, Liao JM, Zarda S, et al.
Open repair of thoracoabdominal aortic aneurysm in the modern sur-
gical era: contemporary outcomes in 509 patients. J Am Coll Surg
2011;212:569-81.
6. Rigberg DA, McGory ML, Zingmond DS, Maggard MA, Agustin M,
Lawrence PF, et al. Thirty-day mortality statistics underestimate the risk
of repair of thoracoabdominal aortic aneurysms: a statewide experience.
J Vasc Surg 2006;43:217-22; discussion 223.
7. Quiñones-Baldrich WJ, Panetta TF, Vescera CL, Kashyap VS. Repair of
type IV thoracoabdominal aneurysm with a combined endovascular and
surgical approach. J Vasc Surg 1999;30:555-60.
8. Resch TA, Greenberg RK, Lyden SP, Clair DG, Krajewski L, Kashyap
VS, et al. Combined staged procedures for the treatment of thoracoab-
dominal aneurysms. J Endovasc Ther 2006;13:481-9.
9. Anderson JL, Adam DJ, Berce M, Hartley DE. Repair of thoracoab-
dominal aortic aneurysms with fenestrated and branched endovascular
stent grafts. J Vasc Surg 2005;42:600-7.
0. Sweet MP, Hiramoto JS, Park KH, Reilly LM, Chuter TA. A standard-
ized multi-branched thoracoabdominal stent-graft for endovascular
aneurysm repair. J Endovasc Ther 2009;16:359-64.EDITORS’ COMMENTARY
Thomas L. Forbes, MD, and Jean-Baptiste Ricco, MD, PhD, London, Ontario, Canada; and Poitiers,
France
Numerous comparisons have been conducted between open repair
(OR) and endovascular repair (ER) of aortic aneurysm, including ran-
domized controlled trials involving infrarenal aortic aneurysms. But no
such randomized controlled trial exists for type IV thoracoabdominalatients that are not eligible for randomization, the need for a large
umber of patients and surgeons with a high level of endovascular skills
equired for branched endovascular stent grafts.
Consequently, the authors have to rely on uncontrolled clin-
cal series comparing these different techniques (ie, conventional
